How should the insulin regimen be adjusted for a patient with a recent A1C of 10% who is currently on sliding‑scale insulin and insulin glargine (100 U/mL)?

Insulin Regimen Adjustment for A1C 10%

Immediately discontinue the sliding scale insulin and intensify the basal insulin glargine using a structured titration algorithm, with consideration for adding prandial insulin if A1C remains above goal after optimizing basal coverage. 1

Critical First Step: Abandon Sliding Scale Insulin

The current regimen with sliding scale insulin is inadequate and should be replaced with a proper basal-bolus approach. Sliding scale insulin is reactive rather than proactive and does not address the underlying insulin deficiency indicated by an A1C of 10%.

Basal Insulin Optimization

Titration Algorithm

Use an evidence-based titration protocol 1:

• Increase basal insulin glargine by 2 units every 3 days until fasting plasma glucose (FPG) reaches goal without hypoglycemia
• Target FPG: <100 mg/dL (5.5 mmol/L) to achieve A1C <7%
• For hypoglycemia: If it occurs without clear reason, reduce dose by 10-20% 1
• Reassess every 3-6 months to avoid therapeutic inertia 1

Expected Dosing

If the patient is insulin-naive or on minimal basal insulin:

• Current dose should be assessed and likely needs significant upward titration
• Average increases of 14 units over 6 months are typical when optimizing control 2
• Monitor for signs of overbasalization (elevated bedtime-to-morning glucose differential, hypoglycemia, high glucose variability) 1

Adding Prandial Insulin

If A1C remains above goal after optimizing basal insulin 1:

Initial Prandial Insulin Addition

• Start with one dose at the largest meal or meal with greatest postprandial glucose excursion
• Starting dose: 4 units OR 10% of basal insulin dose 1
• Increase by 1-2 units or 10-15% based on postprandial glucose readings 1

Progression if Needed

If A1C still above goal, proceed stepwise:

1. Add prandial insulin to additional meals
2. Progress to full basal-bolus regimen (basal + prandial with each meal)

Consider GLP-1 Receptor Agonist

Before intensifying to prandial insulin, strongly consider adding a GLP-1 RA or dual GIP/GLP-1 RA 1:

• These agents reduce A1C significantly without increasing hypoglycemia risk
• Provide cardiovascular and renal benefits
• May reduce or eliminate need for prandial insulin
• Can use fixed-ratio combination products (iGlarLixi or IDegLira) if appropriate 1

Critical Monitoring

• Increase frequency of blood glucose monitoring during regimen changes 3
• Check for adequacy of insulin dose at every visit 1
• Prescribe glucagon for emergent hypoglycemia 1
• Reassess and modify regimen every 3-6 months 1

Common Pitfalls to Avoid

1. Therapeutic inertia: With A1C at 10%, aggressive titration is warranted—do not delay intensification 1
2. Continuing sliding scale: This reactive approach will not achieve glycemic control
3. Inadequate titration: Many patients remain undertreated; use structured algorithms rather than conservative adjustments 4
4. Overbasalization: Watch for signs that basal insulin alone is insufficient (high postprandial excursions, hypoglycemia with high A1C) 1

Administration Reminders

Per FDA labeling 3:

• Administer glargine once daily at the same time each day
• Rotate injection sites within same region (abdomen, thigh, or deltoid)
• Never mix or dilute with other insulins
• Do not administer IV or via insulin pump